Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Comment
. 2022 Jul 8;159(1):e3.
doi: 10.1016/j.medcli.2021.10.007. Epub 2021 Nov 13.

Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios

[Article in English, Spanish]
Affiliations
Comment

Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios

[Article in English, Spanish]
Alberto E Calvo Elías et al. Med Clin (Barc). .
No abstract available

PubMed Disclaimer

Comment in

  • Reply.
    Cairoli E, Espinosa G. Cairoli E, et al. Med Clin (Barc). 2022 Jul 8;159(1):e4. doi: 10.1016/j.medcli.2022.01.010. Epub 2022 Mar 14. Med Clin (Barc). 2022. PMID: 35537883 Free PMC article. English, Spanish. No abstract available.

Comment on

References

    1. Cairoli E., Espinosa G. Autoimmune diseases and vaccines against COVID-19. Decision making in uncertain scenarios. Med Clin (Engl Ed). 2021;157:247–252. - PMC - PubMed
    1. Ferguson J., Murugesan K., Banaei N., Liu A. Interferon-gamma release assay testing to assess COVID-19 vaccination response in a SARS-CoV-2 seronegative patient on rituximab: a case report. Int J Infect Dis. 2021;110:229–231. - PMC - PubMed
    1. Bonelli M., Aletaha D. Response to: Correspondence on “SARS-CoV-2 vaccination in rituximab-treated patients: evidence for impaired humoral but inducible cellular immune response” by Bonelli et al. Ann Rheum Dis. 2021;80:e167. - PubMed
    1. Prendecki M., Clarke C., Edwards H., McIntyre S., Mortimer P., Gleeson S., et al. Humoral and T-cell responses to SARS-CoV-2 vaccination in patients receiving immunosuppression. Ann Rheum Dis. 2021;80:1322–1329. - PMC - PubMed